Show simple item record

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

dc.contributor.authorAlwan, Fen_US
dc.contributor.authorHe, Aen_US
dc.contributor.authorMontoto, Sen_US
dc.contributor.authorKassam, Sen_US
dc.contributor.authorMee, Men_US
dc.contributor.authorBurns, Fen_US
dc.contributor.authorEdwards, Sen_US
dc.contributor.authorWilson, Aen_US
dc.contributor.authorTenant-Flowers, Men_US
dc.contributor.authorMarcus, Ren_US
dc.contributor.authorArdeshna, KMen_US
dc.contributor.authorBower, Men_US
dc.contributor.authorCwynarski, Ken_US
dc.date.accessioned2015-03-25T14:09:56Z
dc.date.issued2015-05-15en_US
dc.identifier.issn0269-9370en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/6979
dc.format.extent903 - 910en_US
dc.relation.ispartofAIDSen_US
dc.subjectBurkitt lymphomaen_US
dc.subjectCODOX-M/IVACen_US
dc.subjectHIVen_US
dc.subjectHIV-related lymphomaen_US
dc.subjectnon-Hodgkin lymphomaen_US
dc.subjectrituximaben_US
dc.titleAdding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapyen_US
dc.typeArticle
dc.identifier.doi10.1097/QAD.0000000000000623en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353878100005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue8en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume29en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record